𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bupropion SR Enhances Weight Loss: A 48-Week Double-Blind, Placebo- Controlled Trial

✍ Scribed by Anderson, James W. ;Greenway, Frank L. ;Fujioka, Ken ;Gadde, Kishore M. ;McKenney, James ;O'Neil, Patrick M.

Book ID
109967440
Publisher
Wiley (John Wiley & Sons)
Year
2002
Tongue
English
Weight
67 KB
Volume
10
Category
Article
ISSN
1071-7323

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sulfasalazine in early rheumatoid arthri
Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study
✍ Pekka Hannonen; Timo Möttönen; Mikko Hakola; Martti Oka 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 991 KB

Objective. To investigate the efficacy and tolerability of sulfasalazine (SSZ) in the treatment of early rheumatoid arthritis (RA). Methods. Eighty patients (symptomatic disease <12 months) were randomly assigned to treatment with SSZ or placebo for 48 weeks. Clinical, laboratory, and scintigraphic

Etanercept in Sjögren's syndrome: A twel
Etanercept in Sjögren's syndrome: A twelve-week randomized, double-blind, placebo-controlled pilot clinical trial
✍ Vidya Sankar; Michael T. Brennan; Marc R. Kok; Rose Anne Leakan; Janine A. Smith 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

## Abstract ## Objective To assess the safety and potential efficacy of etanercept in the treatment of Sjögren's syndrome (SS). ## Methods This pilot study was a 12‐week randomized, double‐blind, placebo‐controlled trial of etanercept, with 14 subjects in each group. Patients received 25 mg of e